Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
NY-303
i
Other names:
NY-303, CYT-303
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
CytoLynx Therap, NAYA Bio
Drug class:
GPC-3 inhibitor, Natural cytotoxicity triggering receptor 1 agonist
Related drugs:
‹
RG7686 (1)
BOS-342 (0)
CM350 (0)
ECT204 (0)
ERY974 (0)
NILK-2501 (0)
NILK-3801 (0)
SAR444200 (0)
SENTI-301A (0)
activated CIK-anti-CD3/MUC1/CEA/EpCAM/GPC3 antibody (0)
iCAR-ILC-N101 (0)
SAR443579 (1)
NY-338 (0)
RG7686 (1)
BOS-342 (0)
CM350 (0)
ECT204 (0)
ERY974 (0)
NILK-2501 (0)
NILK-3801 (0)
SAR444200 (0)
SENTI-301A (0)
activated CIK-anti-CD3/MUC1/CEA/EpCAM/GPC3 antibody (0)
iCAR-ILC-N101 (0)
SAR443579 (1)
NY-338 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login